Abstract:Background and objectives: A robust understanding of the natural history of apathy in Parkinson disease (PD) is foundational for developing effective clinical management tools. However, large longitudinal studies are lacking while the literature is inconsistent about even cross-sectional associations. We aimed to determine the longitudinal predictors of apathy development in a large cohort of people with PD and its cross-sectional associations and trajectories over time, using sophisticated Bayesian modeling techniques. Methods: People with PD followed up in the longitudinal New Zealand Parkinson's progression project were included. Apathy was defined using the neuropsychiatric inventory subscale ≥4, and analyses were also repeated using a less stringent cutoff of ≥1. Both MoCA and comprehensive neuropsychological testing were used as appropriate to the model. Depression was assessed using the hospital anxiety and depression scale. Cross-sectional Bayesian regressions were conducted, and a multistate predictive model was used to identify factors that predict the initial onset of apathy in nonapathetic PD, while also accounting for the competing risk of death. The relationship between apathy presence and mortality was also investigated. Results: Three hundred forty-six people with PD followed up for up to 14 years across a total of 1,392 sessions were included. Apathy occurrence did not vary significantly across the disease course (disease duration odds ratio [OR] = 0.55, [95% CI 0.28-1.12], affecting approximately 11% or 22% of people at any time depending on the NPI cutoff used. Its presence was associated with a significantly higher risk of death after controlling for all other factors (hazard ratio [HR] = 2.92 [1.50-5.66]). Lower cognition, higher depression levels, and greater motor severity predicted apathy development in those without motivational deficits (HR [cognition] = 0.66 [0.48-0.90], HR [depression] = 1.45 [1.04-2.02], HR [motor severity] = 1.37 [1.01-1.86]). Cognition and depression were also associated with apathy cross-sectionally, along with male sex and possibly lower dopaminergic therapy level, but apathy still occurred across the full spectrum of each variable (OR [cognition] = 0.58 [0.44-0.76], OR [depression] = 1.43 [1.04-1.97], OR [female sex] = 0.45 [0.22-0.92], and OR [levodopa equivalent dose] = 0.78 [0.59-1.04]. Discussion: Apathy occurs across the PD time course and is associated with higher mortality. Depressive symptoms and cognitive impairment in particular predict its future development in those with normal motivation.

Evolution of Apathy in Early Parkinson's Disease: A 4-Years Prospective Cohort Study

Cross-Sectional and Longitudinal Association of Clinical and Neurocognitive Factors With Apathy in Patients With Parkinson Disease

Apathy in Drug-Naïve Patients with Parkinson's Disease

Analysis of Influencing Factors of Apathy in Patients with Parkinson's Disease.

Apathy in Lewy body disease and its effects on functional impairment over time

Progression of Fatigue in Early Parkinson's Disease: A 3-Year Prospective Cohort Study

Prevalence and associated factors of apathy in Chinese ALS patients

Relationship between emotional apathy and motor symptoms, sleep and cognitive function in patients with early Parkinson′s disease

Apathy in Parkinson's Disease: Defining the Park Apathy Subtype

A Study of Prospective Memory in Patients with Parkinson's Disease and Emotional Apathy

Prognostic Importance of Apathy in Syndromes Associated with Frontotemporal Lobar Degeneration.

Clinical characteristics of early Parkinson′s disease patients with emotional apathy and its relationship with other non-motor symptoms

Apathy in Parkinson's Disease: Clinical Patterns and Neurobiological Basis

Impulse Control Behaviors and Apathy Commonly Co-Occur in De Novo Parkinson's Disease and Predict the Incidence of Levodopa-Induced Dyskinesia.

White matter hyperintensities: a marker for apathy in Parkinson's disease without dementia?

Longitudinal evolution of non-motor symptoms in early Parkinson’s disease: a 3-year prospective cohort study

Apathy as a Risky Neuropsychiatric Syndrome of Progression From Normal Aging to Mild Cognitive Impairment and Dementia: A Systematic Review and Meta-Analysis

Anatomical correlates of apathy and impulsivity co-occurrence in early Parkinson’s disease

Mixed effects models but not t-tests or linear regression detect progression of apathy in Parkinson's disease over seven years in a cohort: a comparative analysis

Abnormal Spontaneous Neural Activity in Parkinson’s Disease With “pure” Apathy

Apathy After Stroke